Tobin W Juvenal

Chief Commercial Officer · Castle Biosciences

Tobin W Juvenal (Chief Commercial Officer) filed 10 Form 4 reports in the trailing twelve months (0 purchases, 10 sales), most often in Castle Biosciences, Inc. (CSTL). The largest single filing was $527K of CSTL (20,863 sh × $25.24, as filed), executed Mar 12. Data as of Nov 8 2026.

Add to watchlist

Return, ttmiAverage return per filing, trailing twelve months

–

no purchases on file

Delay-adjustediThe same average, entered at disclosure dates

–

returns measure stock purchases only

Filings, ttm

0 buys · 10 sells

Median delay

–

measured on stock purchases

Volume, ttmiDollar value disclosed in the trailing twelve months

$2.6M

shares × price, as filed

Last traded

Oct 28

Filed Oct 30

Median ADV $11.6M across their filed names

Open performance→

Volume by month

Buys $0 Sells $2.8M

Shares × price, as filed · by filing month · past 24 months

Sectors filed on

Healthcare 10 filings

Sector per market data · by filing · past 12 months

Most traded names

CSTL

Castle Biosciences, Inc. CSTL · 0 buys · 10 sells 10 filings

Recent filings

CSTLSALE Castle Biosciences, Inc. View filing → $196K
5,341 sh × $36.62
Exec Oct 28
Filed Oct 30 · 4:06 PM ET CSTLSALE Castle Biosciences, Inc. View filing → $109K
3,288 sh × $33.08
Exec Oct 26
Filed Oct 28 · 4:08 PM ET CSTLSALE Castle Biosciences, Inc. View filing → $111K
3,288 sh × $33.64
Exec Oct 12
Filed Oct 14 · 4:06 PM ET CSTLSALE Castle Biosciences, Inc. View filing → $197K
5,543 sh × $35.50
Exec Sep 29
Filed Oct 1 · 4:21 PM ET CSTLSALE Castle Biosciences, Inc. View filing → $223K
6,600 sh across 2 lots
Exec Sep 14
Filed Sep 16 · 4:20 PM ET CSTLSALE Castle Biosciences, Inc. View filing → $317K
9,050 sh × $35.04
Exec Aug 25
Filed Aug 27 · 4:38 PM ET CSTLSALE Castle Biosciences, Inc. View filing → $450K
15,419 sh across 2 lots
Exec Jul 31
Filed Aug 4 · 4:36 PM ET CSTLSALE Castle Biosciences, Inc. View filing → $527K
20,863 sh × $25.24
Exec Mar 12
Filed Mar 16 · 5:30 PM ET More filings →